Dawn Giangiulio - Aug 13, 2021 Form 3 Insider Report for Design Therapeutics, Inc. (DSGN)

Role
Principal Accounting Officer
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Stock symbol
DSGN
Transactions as of
Aug 13, 2021
Transactions value $
$0
Form type
3
Date filed
8/17/2021, 07:21 PM
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DSGN Common Stock 7.5K Aug 13, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DSGN Stock option (right to buy) Aug 13, 2021 Common Stock 12.3K $0.95 Direct F1
holding DSGN Stock option (right to buy) Aug 13, 2021 Common stock 24.5K $0.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares vested on March 30, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter.
F2 25% of the shares shall vest on December 7, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter.